Please assess the completion status of the following clinical trial:

Trial Title: Radial Optic Neurotomy in Central Retinal Vein Occlusion : a Randomized Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Central Retinal Vein Occlusion oedematous or hemorrhagic (at fundus exam and at fluorescein angiography)~* Visual Acuity (VA) ≤ 20/200 with ETDRS charts~* Decreased VA since more than 1 month, less than 3 months~* Common care recommendations for CRVO during the period before recruitment (Control ocular pressure if associated hypertension or glaucoma ; Hemodilution if hematocrit ≥ 38% ,if no cardio-vascular contra-indication, to maintain hematocrit under 38% during 6 weeks ; Troxerutin (3 /d) and aspirin (100 - 160 mg/d) ; Clinical and angiographic controls to look for retinal ischemia indicating laser PRP to prevent neovascular glaucoma.~* Signed informed consent.~Exclusion Criteria:~* Ischemic CRVO : 1- More than 30 disc diameters of ischemia at fluorescein angiography and/or •2- If Angiogram is uninterpretable because of hemorrhages, deficit of afferent pupillary reflex 0.9 with photographic filters (proposed by Hayreh) with indication to do laser PRP or laser PRP already done,~* Rubeosis or neovascular glaucoma,~* Bilateral diabetic retinopathy preproliferative or proliferative,~* Uncharacterized coagulation disease, or anticoagulant treatment,~* Untreated systemic disease (diabetes, severe high blood pressure, Cardiac failure) ou eye disease (glaucoma),~* Contra-indication or documented allergy to troxerutin or platelet anti-aggregating agents,~* Contra-indication to surgical procedure~* incapacity to received an informed consent, incapacity to follow all the study schedule

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: NO_INTERVENTION): Standard treatment of central retinal vein occlusion : the rheologic correction
- 2 (Type: EXPERIMENTAL): Standard treatment of central retinal vein occlusion : the rheologic correction and surgery associating pars plana vitrectomy and radial optic neurotomy

Based on this trial design, predict the completion outcome and termination type (if applicable).